Bank of New York Mellon Corp - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$2,508,844
-19.5%
130,533
+6.5%
0.00%0.0%
Q2 2023$3,116,187
-27.9%
122,588
+2.6%
0.00%0.0%
Q1 2023$4,320,070
-10.4%
119,504
-1.9%
0.00%0.0%
Q4 2022$4,821,933
-30.9%
121,766
-18.7%
0.00%
-50.0%
Q3 2022$6,983,000
-52.2%
149,854
-55.0%
0.00%
-33.3%
Q2 2022$14,610,000
-41.8%
333,337
-3.9%
0.00%
-40.0%
Q1 2022$25,085,000
-13.7%
346,816
-3.3%
0.01%0.0%
Q4 2021$29,076,000
-32.0%
358,656
-2.4%
0.01%
-37.5%
Q3 2021$42,778,000
-28.8%
367,561
+1.5%
0.01%
-33.3%
Q2 2021$60,045,000
+20.4%
362,181
+1.3%
0.01%
+20.0%
Q1 2021$49,851,000
-17.8%
357,361
+2.0%
0.01%
-23.1%
Q4 2020$60,624,000
+27.5%
350,216
+2.6%
0.01%
+8.3%
Q3 2020$47,552,000
+18.5%
341,366
+1.6%
0.01%
+9.1%
Q2 2020$40,124,000
+25.9%
335,849
+5.3%
0.01%0.0%
Q1 2020$31,874,000
-23.7%
318,795
-10.3%
0.01%0.0%
Q4 2019$41,794,000
-8.9%
355,574
-33.4%
0.01%
-15.4%
Q3 2019$45,871,000
+40.9%
533,562
+6.2%
0.01%
+44.4%
Q2 2019$32,562,000
+16.1%
502,248
+11.9%
0.01%
+12.5%
Q1 2019$28,052,000
+45.5%
448,772
-9.5%
0.01%
+33.3%
Q4 2018$19,275,000
-29.0%
495,672
+4.0%
0.01%
-14.3%
Q3 2018$27,163,000
-17.9%
476,548
+14.9%
0.01%
-22.2%
Q2 2018$33,105,000
-13.8%
414,587
-6.5%
0.01%
-18.2%
Q1 2018$38,423,000
+48.6%
443,322
+18.4%
0.01%
+57.1%
Q4 2017$25,854,000
-17.9%
374,464
+8.0%
0.01%
-22.2%
Q3 2017$31,505,000
+256.8%
346,682
+192.3%
0.01%
+350.0%
Q2 2017$8,829,000
-33.3%
118,611
-16.0%
0.00%
-50.0%
Q1 2017$13,229,000
+43.8%
141,178
+11.5%
0.00%
+33.3%
Q4 2016$9,197,000
-41.1%
126,577
-15.4%
0.00%
-40.0%
Q3 2016$15,622,000
+35.4%
149,651
-4.3%
0.01%
+25.0%
Q2 2016$11,539,000
+50.5%
156,441
+14.8%
0.00%
+100.0%
Q1 2016$7,666,000
-15.6%
136,261
+1.3%
0.00%
-33.3%
Q4 2015$9,085,000
+52.0%
134,553
+4.4%
0.00%
+50.0%
Q3 2015$5,978,000
-14.9%
128,853
-1.4%
0.00%0.0%
Q2 2015$7,026,000
+104.1%
130,709
+82.0%
0.00%
+100.0%
Q1 2015$3,442,000
+204.9%
71,816
+146.0%
0.00%
Q4 2014$1,129,00029,1930.00%
Other shareholders
NEVRO CORP shareholders Q3 2018
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders